ebook Munafa Stock Market Course + Intraday & FNO calls  

       

500660 announcements Glaxosmith announcements and dividends declared BSE

Glaxosmith Complete list of announcements declared & dividend announcements by Glaxosmith 500660

Glaxosmith 500660 listed on BSE and deals in

Announcements and dividends declared by Glaxosmith 500660

GlaxoSmithKline to ship 600,000 more doses of COVID treatment sotrovimab to U.S.
GlaxoSmithKline and partner Vir Biotechnology said Tuesday that the U.S. government will buy 600,000 doses of sotrovimab, an investigational monoclonal antibody for early COVID-19 treatment. The extra doses will be delivered in the first quarter of 2022
Announcement as on 11 January 2022

GlaxoSmithKline, Vir increases supply of COVID-19 antibody therapy to Canada to 20,000 doses
GlaxoSmithKline PLC announced Thursday an agreement to supply the Government of Canada with 20,000 doses of Sotrovimab, the COVID-19 monoclonal antibody therapy the company developed with Vir Biotechnology Inc. . The agreement follows Canada's initial ord
Announcement as on 06 January 2022

GlaxoSmithKline says Sotrovimab antibody retains activity against omicron
GlaxoSmithKline says Sotrovimab antibody retains activity against omicron
Announcement as on 02 December 2021

Can Pfizer and GlaxoSmithKline Beat Johnson & Johnson's RSV Vaccine?
There's a big battle shaping up with several large drugmakers developing respiratory syncytial virus (RSV) vaccines. Johnson & Johnson (NYSE: JNJ) recently announced positive results from a phase 2 study of its RSV vaccine candidate. In this Motley Fool Li
Announcement as on 17 October 2021

With China lagging at this point, big opportunity for India in API, says A Vaidheesh, former MD, GlaxoSmithKline Pharmaceuticals
It is a mixed bag but API is definitely a very big element in the pharma industry which is emerging as one of the big component for growth for certain companies. There is also big support from the government for API.
Announcement as on 23 August 2021

Announcements by Glaxosmith first page | Next page | Prev page |

500660 Glaxosmith current price & indicator signals

Moving Averages for Glaxosmith

  • 5Day Average: 2351.26
  • 12Day Average: 2405.7
  • 20Day Average: 2402.07
  • 50Day Average: 2397.46
  • 100Day Average: 2436.45
  • 150Day Average: 2487.03
  • 200Day Average: 2561.43

500660 Indicators & signals

Indicator MACD (12,26,9)

2379.41, 2396.82, -4.56
Indicator MACD is in negative zone

Indicator ADX (14)

17.47, 15.47, 22.02
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 45
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 500660 Glaxosmith are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
22 Fri May 2026 2309.80 2295.00 to 2344.00 -0.47% 0.61 times
21 Thu May 2026 2320.75 2312.40 to 2377.00 -1.14% 0.54 times
20 Wed May 2026 2347.60 2343.60 to 2395.80 -1.73% 0.5 times
19 Tue May 2026 2388.90 2381.00 to 2421.90 -0.01% 0.26 times
18 Mon May 2026 2389.25 2372.10 to 2435.05 -2.07% 0.51 times
15 Fri May 2026 2439.75 2406.05 to 2458.60 0.91% 0.23 times
14 Thu May 2026 2417.75 2404.60 to 2460.65 0.45% 0.26 times
13 Wed May 2026 2406.85 2386.35 to 2493.00 -1.68% 1.16 times
12 Tue May 2026 2448.10 2412.00 to 2491.00 0.5% 0.73 times
11 Mon May 2026 2435.95 2428.95 to 2484.35 -1.96% 0.46 times
08 Fri May 2026 2484.70 2440.00 to 2505.00 0.23% 5.36 times
07 Thu May 2026 2478.95 2432.30 to 2488.40 2.25% 1.82 times

Videos related to: 500660 announcements Glaxosmith announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

500660 announcements Glaxosmith announcements and dividends declared BSE

 

Back to top